Phase 3
18 Years
N/A
Open (Enrolling)
Both
Carcinoma, Squamous Cell

Thank you

Trial Information

Inclusion Criteria


- 18 years or older

- Not eligible for surgery

- Must have had radiation and chemotherapy treatments

- No prior methotrexate treatments

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Principal Investigator

Kerstin Menander, MD

Investigator Role:

Study Director

Authority:

United States: Food and Drug Administration

Study ID:

T301

NCT ID:

NCT00041613

Start Date:

Completion Date:

Related Keywords:

  • Carcinoma, Squamous Cell
  • Refractory Squamous Cell Carcinoma of the Head and Neck
  • Carcinoma
  • Carcinoma, Squamous Cell

Name

Location
Norton Healthcare Pavilion Louisville, Kentucky  40202
Mary Crowley Medical Research Center Dallas, Texas  75246
Unversity of Colorado Cancer Center Aurora, Colorado  80045
Cancer Center of GBMC Baltimore, Maryland  21204
WJB Dorn VA Medical Center Columbia, South Carolina  29209